An eight-mRNA signature outperforms the lncRNA-based signature in predicting prognosis of patients with glioblastoma.
Zhenyu GongFan HongHongxiang WangXu ZhangJuxiang ChenPublished in: BMC medical genetics (2020)
The eight-mRNA signature has greater prognostic value than the ten-lncRNA-based signature for GBM patients based on bioinformatics analysis.